Understanding and reducing suicide risks among veterans is a national concern and a major priority for the Department of Veterans Affairs Veterans Health Administration (VHA) (1) (2) (3) (4) . Each year, the VHA provides health services to approximately 5 million veterans-roughly one-fifth of all veterans living in the United States. The characteristics of the VHA patient population include important suicide risk factors. The VHA serves a predominantly male older population, with substantial medical morbidities, high levels of substance abuse and mental illness, and increased knowledge of and access to firearms (5-7). However, there have been few comprehensive assessments of suicide mortality among veterans generally (8) and none to our knowledge among veterans receiving services in the VHA health system.
In 2007, Congress required the Department of Veterans Affairs to implement a comprehensive suicide prevention program (9) . This legislation reflects concerns regarding the high mental health needs observed among veterans of Operations Enduring Freedom and Iraqi Freedom (10) (11) (12) , the influx of these veterans now eligible for VHA health services (13, 14) , and indications that suicide risks may be elevated among veterans compared with nonveterans. Notably, a highly publicized study observed that, in the period 1986-1997, male respondents to the US National Health Interview Survey (NHIS) who indicated veteran status had greater suicide risks than those who did not (adjusted hazard ratio ¼ 2.04, 95% confidence interval (CI): 1.10, 3.80) (8) .
Even before passage of this legislation, however, the VHA had implemented key provisions and system-level mental health enhancements. Based on its Mental Health Strategic Plan (3), the VHA has worked to ensure access to quality mental health services and to develop programs specifically designed to prevent suicides. For example, since 2005, the VHA has added more than 3,600 mental health staff, and VHA mental health service expenditures increased from $2 billion in fiscal year 2001 to nearly $4 billion in fiscal year 2008 (15) . Evaluation of the impact of ongoing changes in the VHA patient population and of recent VHA mental health and suicide prevention initiatives will require assessment of baseline suicide rates among VHA patients.
Much of the existing research regarding suicide mortality among veterans has focused on combat theater veteran cohorts or veteran subgroups with service-related injuries. These have not found increased rates among combat theater cohorts (16) (17) (18) , but risks have been shown to be higher in association with combat trauma and post-traumatic stress disorder (19, 20) .
The few studies that have examined suicide mortality among VHA patients have been limited to high-risk patient subgroups. Increased risks have been demonstrated in patients receiving depression treatment (21) , those receiving outpatient mental health services (22) , and those who have received psychiatric discharge (23) . However, no study has examined rates for the entire VHA patient population. Indeed, to date there have been no comprehensive assessments of suicide mortality for all patients of any health system or managed care organization.
Patterns of suicide risk across age groups may differ among VHA patients compared with risks in the general population. Older persons are conventionally understood to have higher risks for suicide than younger persons (24) . However, among individuals receiving VHA treatment for depression, Zivin et al. (21) found that suicide risks were highest among younger patients (age, <45 years).
It is also important to consider gender differentials in suicide mortality among patients receiving VHA care. Women veterans are one of the fastest growing segments of the population of veterans eligible for VHA care (25) . In the general population, men are 4 times as likely to die from suicide, although women are 3 times as likely to attempt suicide (15, 26) . However, little is known about gender differences in suicide risks among individuals receiving VHA services. This paper presents new information regarding suicide mortality among all patients receiving VHA services. We We assessed suicide mortality overall and by age and gender categories. VHA suicide rates were compared with those of the general US population.
MATERIALS AND METHODS

Data sources
This study used data from the VHA's National Patient Care Database to identify all veterans with inpatient or outpatient services utilization in any VHA facility during fiscal year 2000 or fiscal year 2001. Measures of vital status and cause of death were based on information from the National Death Index, which is considered the ''gold standard'' for mortality assessment (27) . It includes national data regarding dates and causes of death for all US residents, derived from death certificates filed in state vital statistics offices. National Death Index searches were performed for cohorts of VHA patients who received any VHA services use during fiscal Using National Death Index data, we identified dates and causes of death. Suicide deaths were identified by using International Classification of Diseases, Tenth Revision, codes X60-X84, Y87.0, and U03 (29). We calculated the total suicide deaths observed in fiscal year 2001 divided by the person-years at risk for an observed suicide death. This quotient was then multiplied by 100,000 to generate suicide rates per 100,000 person-years.
Person-years at risk for an observed suicide death were made operational as follows. For those veterans who received VHA services in fiscal year 2000 (and survived that year), the risk period began on the first day of fiscal year 2001. For veterans with no VHA services in fiscal year 2000, the risk period began on the day of their first VHA use in fiscal year 2001. Risk periods ended at either the date of death (from any cause) or the end of the year, whichever came first.
Cohort
The VHA patient population at risk for observed suicide deaths during fiscal year 2001 included all 4,692,034 individuals with VHA inpatient or outpatient services use in fiscal year 2001 or fiscal year 2000 and who were alive at the start of fiscal year 2001. Of these patients, 21,066 (0.4%) were excluded because of missing or out-of-range values for age or gender. Among the excluded patients, 2 suicides were observed. The final cohort consisted of 4,670,968 patients. This project was reviewed and approved by a VHA human subjects committee.
Rates in the US general population
Suicide rates in the general population were identified from the Web-based Injury Statistics Query and Reporting System (WISQARS) (26) . These data are derived from the National Vital Statistics System. Suicide rates in the general population were assessed overall and by age and gender categories. These are available by calendar year. Therefore, rates in the general population were calculated for calendar year 2001.
Analyses
Standardized mortality ratios for suicide risks among VHA patients were calculated for age and gender subgroups compared with those in the general US population (30) . We calculated 95% confidence intervals for the standardized mortality ratios using the exact method based on Poisson distribution (31). Table 2 presents suicide rates among VHA patients compared with the general US population. Overall, for men and women combined, suicide risks among VHA patients were 66% higher than those observed in the general population (age-and gender-adjusted standardized mortality ratio ¼ 1.66, 95% CI: 1.58, 1.75). The crude suicide rate among male VHA patients was 43.1/100,000 person-years, compared with 23.2/100,000 person-years among males in the general population. The standardized mortality ratio for male VHA patients relative to males in the general population, with adjustment for differences in age distributions, was 1.66 (95% CI: 1.58, 1.74). That is, suicide risks among male patients were 66% greater than for males in the general population. Analyses by age subgroups indicated that male VHA patients between 30 and 79 years of age had greater suicide risks than did similarly aged men in the general population. Standardized mortality ratios ranged from 1.33 among VHA patients aged 70-79 (95% CI: 1.20, 1.47) years to 2.56 among patients aged 30-39 (95% CI: 2.13, 3.03) years.
RESULTS
Among female patients, the crude suicide rate was 10.41/ 100,000 person-years, compared with 5.22/100,000 personyears in the general population, with a standardized mortality ratio of 1.87 (95% CI: 1.35, 2.47). Compared with similarly aged women in the general population, female patients had significantly higher risks: For those aged 40-49 years, the standardized mortality ratio was 2.15 (95% CI: 1.25, 3.29), and for those aged 50-59 years, it was 2.36 (95% CI: 1.22, 3.88).
DISCUSSION
Government agencies and the public acknowledge a responsibility to monitor adverse outcomes among individuals discharged from military service. This responsibility is heightened when the government is also responsible for their health care. This study presents new information regarding suicide mortality among the entire patient population of the VHA, representing approximately 5 million veterans. The VHA is the only large health-care organization to assess suicide mortality among its entire patient population. Thus, comparable data regarding suicide mortality in other health system populations are not available-even though health systems are likely to be important venues for suicide prevention efforts. This report from the nation's largest integrated health system provides a heretofore unavailable comparison point for other health systems that may be initiating surveillance of suicide mortality in their populations. Study findings provide a baseline for evaluations of the most comprehensive suicide prevention program ever put into place in a health-care system.
Suicide rates among VHA patients were significantly higher than those in the general US population. However, the differentials between suicide rates for VHA patients and for the general US population were not as large as the differentials previously estimated for veterans compared with nonveterans in the community (8) . Whereas Kaplan et al. (8) reported that risks for male veterans were twice those of male nonveterans in the community (adjusted hazard ratio ¼ 2.04, 95% CI: 1.10, 3.80), we observed an overall standardized mortality ratio of 1.66 (95% CI: 1.58, 1.74) for male VHA patients compared with men in the general population. However, it is difficult to make direct comparisons across studies because of differences in timeframes, populations, and methodologies. Given that VHA patients had sought health services and likely had greater medical and psychiatric morbidity than did veterans in the community, one could expect higher relative risks in this treatmentseeking patient population. Alternatively, treatment populations may have lower suicide risks as a function of increased mental health and substance use care access and treatment. This study provides new information on age-specific differentials in suicide risks among VHA patients relative to age-and gender-matched comparisons in the general population. Among male patients, rates were highest among those aged 30-49 years and lowest among patients aged 18-29 and 60-69 years. The differential in suicide rates for male patients, relative to men in the general population, was highest for patients aged 30-39 years, and it fell among older patient groups. Further research is needed to evaluate whether these patterns reflect cohort effects or age-patterned selection of VHA services among veterans. Among female patients, rates were highest among those aged 50-59 years.
Consistent with the literature, crude rates among female VHA patients were substantially lower than those among male patients. However, compared with women in the general population, female VHA patients had high suicide mortality, with a standardized mortality ratio of 1.87. This is a larger differential than the standardized mortality ratio of 1.66 for male patients.
Increased relative risks among female VHA patients may result from not only the characteristics of treatment-seeking populations generally (e.g., greater morbidity) but also the factors unique to women who have served in the military. Female VHA patients may have greater experience with and access to firearms than do women in the general population, and they may be more likely to have experienced traumatic episodes, increasing risks for both post-traumatic stress disorder and suicide (32) (33) (34) (35) (36) (37) . In designing and implementing suicide prevention initiatives, VHA providers must address suicide risks among both male and female patients. Several issues should be considered when interpreting study findings. First, there are longstanding concerns regarding potential undercounting of suicide deaths. Research is needed to assess potential differential recording of suicide deaths by veteran status. Second, although we compared rates among VHA patients with those among the general US population, we note that VHA patients are included in the general population. Third, we note that the VHA patient population includes some nonveterans (e.g., widows or dependents of veterans), whose utilization accounts for approximately 1% of VHA inpatient admissions and 2% of outpatient visits (38) . This study examined suicide mortality among all VHA patients, of whom the vast majority are veterans. Finally, it was not possible to adjust rates for race. In the general population, suicide rates are lower among minority populations, and minorities may be overrepresented among VHA patients.
Study findings indicate that VHA patients were at increased risks for suicide, yet the differential in risks was less than what might be expected given previous comparisons (8) . Future research is necessary to assess patients' sociodemographic and clinical factors that may be associated with suicide mortality, to assess the impact of specific health-care services on suicide risks among veterans, and to evaluate trends in suicide mortality among VHA patients and among veterans who do not receive VHA care. For health-care providers, and particularly the Veterans Health Administration, research on suicide rates and risk factors among veterans may directly inform treatment and suicide prevention interventions.
